Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
Public ClinicalTrials.gov record NCT03272685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace Part of "Evaluating New Nicotine Standards for Cigarettes"
Study identification
- NCT ID
- NCT03272685
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- University of Minnesota
- Other
- Enrollment
- 799 participants
Conditions and interventions
Conditions
Interventions
- Normal Nicotine Content Cigarettes Drug
- Very Low Nicotine Content Cigarettes Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2018
- Primary completion
- Sep 29, 2022
- Completion
- Jan 9, 2023
- Last update posted
- Aug 19, 2024
2018 – 2023
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tobacco Research Center | San Francisco | California | 94110 | — |
| Tobacco Research Programs | Minneapolis | Minnesota | 55414 | — |
| The Center for Addiction Science and Technology | Durham | North Carolina | 27705 | — |
| Wake Forest Tobacco Control Center of Excellence | Winston-Salem | North Carolina | 27175 | — |
| Center for Interdisciplinary Research on Nicotine Addiction | Philadelphia | Pennsylvania | 19104 | — |
| Brown University Center for Alcohol and Addiction Studies School of Public Health | Providence | Rhode Island | 02912 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03272685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2024 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03272685 live on ClinicalTrials.gov.